Patients with varicose veins.. Varicose veins of lower extremities
Conditions
Interventions
Intervention 1: The intervention group will receive 500 mg capsules of calcium dobesilate (Doxium) (from Barsian Darou Company) three times daily for a duration of two months. This medication is presc
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years Confirmed diagnosis of grade 1 to 3 varicose veins of the lower extremities, verified by color Doppler ultrasound Written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: History of underlying systemic diseases such as heart failure, liver, or kidney disease Presence of other significant vascular disorders, such as uncontrolled diabetes, hypertension, recent phlebitis, or deep vein thrombosis Presence of primary or secondary lymphedema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom score. Timepoint: The primary outcome will be measured at baseline (before the intervention), and one month after the end of the intervention. Method of measurement: five-point categorical scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain Severity. Timepoint: The primary outcome will be measured at baseline (before the intervention), and one month after the end of the intervention. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPezhman Farshidmehr
Tehran University of Medical Sciences
Outcome results
None listed